Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Boehringer Ingelheim Pharmaceuticals Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified medical advice, visits or professional assistance with a real dr.. We aren't docs. Always consult your mD about Boehringer Ingelheim Pharmaceuticals clinical studies. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Boehringer Ingelheim Pharmaceuticals Clinical research trials and Boehringer Ingelheim Pharmaceuticals medical trials happen in many of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectiveness of new drugs. The propose of the studies / projects is to figure out particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies like Boehringer Ingelheim Pharmaceuticals to find cures for all sorts of conditions. Boehringer Ingelheim Pharmaceuticals Clinical Trials and other clinical trials permit volunteers to acquire health treatment choices before they are available to the general public. Some times the subjects receive treatment for free of charge, and occasionally they are compensated for their time. Occasionally there is a cost for a Boehringer Ingelheim Pharmaceuticals clinical trial. Human subjects oftentimes recieve the most expert healthcare available for their condition. Dangers are a reality, nevertheless, and might include extra or frequent dr. calls, healthcare risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "B" Clinical Trials Sponsors > Boehringer Ingelheim Pharmaceuticals Clinical Trials

Boehringer Ingelheim Pharmaceuticals Clinical Trials



A multi-center trial to compare the efficacy and safety of three doses of Meloxicam and placebo in patients with Rheumatoid Arthritis.
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients with Progressive HIV Disease
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients with HIV Infection (CD4+ Cell Count < 400/mm3)
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Dose ranging trial of tipranavir/ritonavir in treatment-experienced HIV infected individuals
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Dual Boosted- PI PK trial
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Efficacy and Safety of 24 Weeks of Oral Treatment with BIIL 284 BS in Adult and Pediatric Patients
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Evaluation Of Three Doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer’s Type
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Meloxicam suspension in Juvenile Rheumatoid Arthritis (JRA)
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Outcome Study ONTARGET
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Pharmacokinetics and Safety Study of Tipranavir in Combination with Low Dose Ritonavir in HIV-Infected Children
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

RESIST 1: Randomized Evaluation of Strategic Intervention in Multi-Drug Resistant Patients with Tipranavir
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

Telmisartan vs. valsartan missed dose
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined with MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals



Boehringer Ingelheim Pharmaceuticals Clinical Trials
Modify your Search

Other "B" Clinical Trials Sponsors:

Baker Norton Pharmaceuticals
Baptist Hospital Of Miami
Barbara Ann Karmanos Cancer Institute
Barr Laboratories
Barrett Cancer Center
Bayer Corporation
Baylor College Of Medicine
Baylor University
Beckman Research Institute
Berlex Laboratories
Beth Israel Deaconess Medical Center
Biocodex
Biocryst Pharmaceuticals
Biocure Medical
Biogen Idec
Bioheart, Inc.
Biomarin Pharmaceutical
Biomeasure Inc, Ipsen Group
Biomedicines
Biomira Inc.
Bionumerik Pharmaceuticals, Inc.
Blood And Marrow Transplant Clinical Trials Network
Blumenthal Cancer Center At Carolinas Medical Center
Boehringer Ingelheim Pharmaceuticals
Boston Medical Center
Boston University School Of Medicine
Breast International Group
Brigham And Women's Hospital
Bristol-Myers Squibb
British Association Of Surgical Oncology: Breast Group
British Biotech Pharmaceuticals
British Columbia Cancer Agency
British National Lymphoma Investigation
British Thoracic Society
Burroughs Wellcome
Burzynski Research Institute


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103